Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 75

Results For "General"

845 News Found

We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare
interviews | October 20, 2021

We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare

Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.

FDA approves Cyltezo, the first interchangeable biosimilar to Humira
Drug Approval | October 20, 2021

FDA approves Cyltezo, the first interchangeable biosimilar to Humira

Second interchangeable biosimilar product approved by agency

Vertex’s stem cell therapy for Type 1 diabetes reduced daily insulin requirement by 91 %
Biotech | October 19, 2021

Vertex’s stem cell therapy for Type 1 diabetes reduced daily insulin requirement by 91 %

The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit

GPT Healthcare to go public to fund expansion
Hospitals | October 18, 2021

GPT Healthcare to go public to fund expansion

The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India

Govt. removes export curbs on Covid-19 kits
Policy | October 16, 2021

Govt. removes export curbs on Covid-19 kits

The export policy of all diagnostic kits and reagents (including instruments /apparatus) ... is being made free with immediate effect," the directorate general of foreign trade (DGFT) said in a notification

SecureKloud to list subsidiary Healthcare Triangle on Nasdaq
News | October 13, 2021

SecureKloud to list subsidiary Healthcare Triangle on Nasdaq

The company plans to raise US $ 15 million

Skanray to raise Rs 400 crore to fund its inorganic growth
News | October 12, 2021

Skanray to raise Rs 400 crore to fund its inorganic growth

Since its inception, the company has either acquired or taken a majority stake in five companies

Covaxin for kids gets nod, final approval awaited
Drug Approval | October 12, 2021

Covaxin for kids gets nod, final approval awaited

The two doses of Covaxin are likely to be administered to children with a gap of 28 days

Astra’s antibody injection trial indicates it can prevent and treat Covid-19
Biotech | October 11, 2021

Astra’s antibody injection trial indicates it can prevent and treat Covid-19

AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial

WHO gives its go-ahead for first-ever malaria vaccine
Drug Approval | October 07, 2021

WHO gives its go-ahead for first-ever malaria vaccine

It recommends using the vaccine to prevent the spread of the disease

Latest Stories

Aster DM Healthcare to build Rs. 580 crore crore hospital in Bengaluru

Sanofi Consumer Healthcare India reports Q2 2025 PAT at Rs. 60.7 Cr

Eli Lilly inaugurates global capability centre in hyderabad to advance AI initiatives

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging